Our division engages in both interventional and observational studies. Each clinical trial has its own set of inclusion/exclusion criteria for recruitment.
Clinical Research Focus Areas
AATD is a genetic disease that can affect the liver or lungs. The alpha-1 protein is designed to protect tissues in the body from being attacked by its own enzymes.
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to describe progressive lung diseases including emphysema, chronic bronchitis, and refractory (non-reversible) asthma. This disease is characterized by increasing breathlessness.
Cystic Fibrosis (CF) is an inherited disease that affects the lung, digestive system, sweat glands, & male fertility. Because CF is genetic, clinical research is the only way to develop better treatments and, hopefully, a cure for CF in the near future.
Idiopathic Pulmonary Fibrosis (IPF) results in scarring of the lungs. The cause of the scarring (fibrosis) is not known, and the damage makes it difficult for the patient to take in oxygen.
Pulmonary Arterial Hypertension affects people of all ages and races. There are several conditions that lead to pulmonary hypertension and there are many different types of the disease.
Pulmonary division Research Laboratories have over 10,000 sq.ft. of research space, both at the VA Hospital and at other university facilities. They are equipped with state-of-the-art equipments, including computers and confocal microscopy.